Celso Martins Queiroz-Junior
Overview
Explore the profile of Celso Martins Queiroz-Junior including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
834
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sa M, Queiroz-Junior C, de Souza P, Diniz I, Oliveira M, Grossmann S, et al.
J Oral Biol Craniofac Res
. 2024 Jan;
14(1):79-85.
PMID: 38282697
Objective: to evaluate the effects of the red and near-infrared wavelength lasers in isolated and simultaneous way on the modulation of inflammatory cytokines produced by human keratinocytes (HaCaT) challenged by...
12.
Guimaraes L, Costa P, Ricardo Aluotto Scalzo Junior S, Athaydes Seabra Ferreira H, Braga A, de Oliveira L, et al.
Nat Commun
. 2024 Jan;
15(1):590.
PMID: 38238326
A safe and effective vaccine with long-term protection against SARS-CoV-2 variants of concern (VOCs) is a global health priority. Here, we develop lipid nanoparticles (LNPs) to provide safe and effective...
13.
Santos F, Costa V, Araujo S, de Sousa C, Moreira T, Goncalves M, et al.
J Virol
. 2024 Jan;
98(1):e0110223.
PMID: 38169294
Mayaro virus (MAYV) is an emerging arbovirus member of the family and genus. MAYV infection causes an acute febrile illness accompanied by persistent polyarthralgia and myalgia. Understanding the mechanisms involved...
14.
Pimenta J, Oliveira B, Lima A, Machado C, Lacerda L, Rossi L, et al.
Inflamm Res
. 2023 Oct;
72(10-11):2073-2088.
PMID: 37837557
Objective And Design: The present study aimed to investigate the neurochemical and behavioral effects of the acute consequences after coronavirus infection through a murine model. Material: Wild-type C57BL/6 mice were...
15.
Rossi L, Santos K, Mota B, Pimenta J, Oliveira B, Machado C, et al.
Neurochem Int
. 2023 Jun;
169:105567.
PMID: 37348761
COVID-19 affects primarily the lung. However, several other systemic alterations, including muscle weakness, fatigue and myalgia have been reported and may contribute to the disease outcome. We hypothesize that changes...
16.
Martins F, de Oliveira M, Souza J, Queiroz-Junior C, Pereira Lobo F, Teixeira M, et al.
Front Immunol
. 2023 Jun;
14:1175275.
PMID: 37275853
Ethanol abuse is a risk factor for the development of pneumonia caused by , a critical pathogen for public health. The aim of this article was to investigate the inflammatory...
17.
Vieira-Alves I, Rodrigues Pereira Alves A, Souza N, Melo T, Campos L, Lacerda L, et al.
Clin Sci (Lond)
. 2023 Mar;
137(7):543-559.
PMID: 36972169
Poor disease outcomes and lethality are directly related to endothelial dysfunction in betacoronavirus infections. Here, we investigated the mechanisms underlying the vascular dysfunction caused by the betacoronaviruses MHV-3 and SARS-CoV-2....
18.
Vago J, Zaidan I, Perucci L, Brito L, Teixeira L, Silva C, et al.
JCI Insight
. 2023 Mar;
8(8).
PMID: 36917195
Sepsis is a lethal syndrome characterized by systemic inflammation and abnormal coagulation. Despite therapeutic advances, sepsis mortality remains substantially high. Herein, we investigated the role of the plasminogen/plasmin (Plg/Pla) system...
19.
Santos M, Chaves I, Queiroz-Junior C, Cramer A, Anestino T, Santos A, et al.
Inflamm Res
. 2023 Mar;
72(4):859-873.
PMID: 36912916
Introduction: The role of suppressor of cytokine signaling 2 (SOCS2) in Aggregatibacter actinomycetemcomitans (Aa)-induced alveolar bone loss is unknown; thus, it was investigated in this study. Methods: Alveolar bone loss...
20.
Souza T, Pinho V, Setim C, Sacramento C, Marcon R, Fintelman-Rodrigues N, et al.
Nat Commun
. 2023 Jan;
14(1):199.
PMID: 36639383
Orally available antivirals against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are necessary because of the continuous circulation of new variants that challenge immunized individuals. Because severe COVID-19 is a...